Recruiting Scleroderma Studies in Omaha
About Scleroderma Clinical Trials in Omaha
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 1 scleroderma clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 1,072 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Omaha — FAQ
Are there scleroderma clinical trials in Omaha?
Yes, there are 1 scleroderma clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 1 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated October 17, 2026 from ClinicalTrials.gov